This kit is used for in vitro qualitative detection of BRAF V600E point mutation in patients with non-small cell lung cancer(NSCLC), colorectal cancer, and thyroid cancer. Evaluate gene mutation status by detecting DNA samples, the assay results can be used as the reference for clinicians’ selection of tumor-targeted drugs in patients with colorectal cancer, thyroid cancer or lung cancer